These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 3925727)

  • 21. The TRH stimulation test and the dexamethasone suppression test in depression.
    Dam H; Mellerup ET; Rafaelsen OJ
    Psychiatry Res; 1986 Apr; 17(4):309-16. PubMed ID: 3086912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent neuroendocrine dysregulation in major depressive disorder: a marker for early relapse.
    Targum SD
    Biol Psychiatry; 1984 Mar; 19(3):305-18. PubMed ID: 6426529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The dexamethasone suppression test and thyroid stimulating hormone response to TRH in RDC schizoaffective patients.
    Sauer H; Koehler KG; Sass H; Hornstein C; Minne HW
    Eur Arch Psychiatry Neurol Sci; 1984; 234(4):264-7. PubMed ID: 6441714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dexamethasone suppression and thyrotropin-releasing hormone tests in depressed borderline patients.
    Sternbach HA; Fleming J; Extein I; Pottash AL; Gold MS
    Psychoneuroendocrinology; 1983; 8(4):459-62. PubMed ID: 6425891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationships among the TRH, REM latency, and dexamethasone suppression tests: preliminary findings.
    Rush AJ; Schlesser MA; Roffwarg HP; Giles DE; Orsulak PJ; Fairchild C
    J Clin Psychiatry; 1983 Aug; 44(8 Pt 2):23-9. PubMed ID: 6409892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychopathological correlates of plasma cortisol after dexamethasone suppression: a polydiagnostic approach.
    Philipp M; Maier W; Holsboer F
    Psychoneuroendocrinology; 1986; 11(4):499-507. PubMed ID: 3562743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The application of serial neuroendocrine challenge studies in the management of depressive disorder.
    Targum SD
    Biol Psychiatry; 1983 Jan; 18(1):3-19. PubMed ID: 6403062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of biologic markers in a general hospital affective disorders program.
    Lieber AL; Newbury N
    J Clin Psychiatry; 1985 Jun; 46(6):217-21. PubMed ID: 3922959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TRH test and DST in schizoaffective mania, mania, and schizophrenia.
    Kiriike N; Izumiya Y; Nishiwaki S; Maeda Y; Nagata T; Kawakita Y
    Biol Psychiatry; 1988 Aug; 24(4):415-22. PubMed ID: 2900656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationships of neuroendocrine tests in endogenous depression.
    Arató M; Rihmer Z; Bánki CM; Grof P
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):715-8. PubMed ID: 6420844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depression and the Newcastle Scale. Their relationship to the dexamethasone suppression test.
    Holden NL
    Br J Psychiatry; 1983 May; 142():505-7. PubMed ID: 6871564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosing depression with the DST and TRH in cocaine and opioid abusers.
    Kosten TR
    J Subst Abuse Treat; 1986; 3(1):47-9. PubMed ID: 3090273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of four definitions of melancholia by the dexamethasone suppression test.
    Davidson J; Lipper S; Zung WW; Strickland R; Krishnan R; Mahorney S
    Am J Psychiatry; 1984 Oct; 141(10):1220-3. PubMed ID: 6486256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serial DST, TRH test, and TRH-like immunoreactivity measurements in major affective disorders.
    Itoh N; Matsui N; Fuwano S; Yaginuma H; Miyashita O; Sakai M
    Biol Psychiatry; 1987 May; 22(5):559-72. PubMed ID: 3107620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Biologic diagnosis of depression by the TRH and dexamethasone tests].
    Chabrol H; Moron P
    Encephale; 1983; 9(1):1-22. PubMed ID: 6135596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of thyrotropin-releasing hormone test and dexamethasone suppression test abnormalities in unipolar depression.
    Extein I; Pottash AL; Gold MS
    Psychiatry Res; 1981 Feb; 4(1):49-53. PubMed ID: 6784138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depression dexamethasone nonsuppression and negative symptoms in schizophrenia.
    Addington D; Addington J
    Can J Psychiatry; 1990 Jun; 35(5):430-3. PubMed ID: 2372754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The specificity of the thyrotropin-releasing hormone (TRH) test and dexamethasone suppression test (DST) for major depressive illness in alcoholics.
    Dackis CA; Pottash AL; Bailey J; Stuckey RF; Extein IL; Gold MS
    NIDA Res Monogr; 1983 Apr; 43():266-72. PubMed ID: 6410260
    [No Abstract]   [Full Text] [Related]  

  • 39. TRH stimulation and dexamethasone suppression in borderline personality disorder.
    De la Fuente JM; Mendlewicz J
    Biol Psychiatry; 1996 Sep; 40(5):412-8. PubMed ID: 8874844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The dexamethasone suppression test in borderlines: is it useful?
    Korzekwa M; Steiner M; Links P; Eppel A
    Can J Psychiatry; 1991 Feb; 36(1):26-8. PubMed ID: 2029680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.